2026-03-07 – Press Releases – www.prnewswire.com
SHANGHAI, March 7, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson’s disease using ivonescimab, a novel immunotherapy currently available only in China. The 70‑something patient had…
